What is it about?
In this editorial I introduce a Special Issue of the journal Antibiotics that I edited, entitled Antibiotic Use in Clinical Infection: How to Reinvent Old Molecules and How to Squeeze out New Ones. With few truly new antibiotics reaching the market and resistance continuing to grow, clinicians must use every available drug as wisely as possible. The articles collected in the issue explore two complementary strategies: rediscovering older antibiotics, for example by using them in new combinations, new dosing schemes or new clinical indications, and optimizing the use of recently approved drugs, based on pharmacokinetic and pharmacodynamic principles and real-world clinical experience.
Featured Image
Photo by Towfiqu barbhuiya on Unsplash
Why is it important?
Making smarter use of existing antibiotics is one of the most effective and immediate responses to antimicrobial resistance. This Special Issue offers clinicians practical insights on how to extend the useful life of both old and new molecules, in line with antimicrobial stewardship principles.
Perspectives
I have always believed that old antibiotics still have a lot to say, as my work on fosfomycin and other molecules shows. Editing this Special Issue allowed me to bring together colleagues who share the same idea: before waiting for new drugs, we should learn to use better those we already have.
Professor Stefano Di Bella
Universita degli Studi di Trieste
Read the Original
This page is a summary of: Editorial for the Special Issue: “Antibiotic Use in Clinical Infection: How to Reinvent Old Molecules and How to Squeeze out New Ones”, Antibiotics, April 2022, MDPI AG,
DOI: 10.3390/antibiotics11050597.
You can read the full text:
Contributors
The following have contributed to this page







